• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

New York Physician Calls for Global Research Into CBD and Addiction

March 8, 2018

 

“If this is something that could be potentially beneficial, and there’s an indication that it could be beneficial, why not put all hands on deck?” ~ Dr. Yasmin Hurd

 

Can a non-psychoactive cannabinoid help recovering addicts avoid relapse? Dr. Yasmin Hurd seeks to answer this question by creating a global syndicate of researchers to study the correlation between cannabidiol (CBD) and addiction recovery, according to PBS.

 

Dr. Hurd, the Director of the Addiction Institute at the Icahn School of Medicine at Mount Sinai Hospital in New York, is creating a worldwide consortium of scientists to study cannabidiol (CBD) and scrutinize its potential use in quelling addiction.

 

In 2017 the National Institute on Drug Abuse reported that roughly 64,000 Americans overdosed during the prior year.

 

Hurd, a professor of psychiatry and neuroscience, said she believes the CBD cannabinoid holds the key to suppressing obsessive cravings for opioids and heroin. A member of the National Academy of Medicine, Dr. Hurd has asked the global scientific community to help research the intriguing interaction between cannabidiol and addiction recovery.

 

Calling for all scientific “hands on deck,” Hurd believes there’s a strong chance the second most prominent cannabinoid found in marijuana could dramatically help reduce America’s addiction to heroin, opioids, and other addictive pharmaceuticals.

 

In Hurd’s initial research, she discovered cannabidiol reportedly “decreased cravings and anxiety without producing any psychoactive effects” in the test animals. Unclear as to the cause-and-effect, Dr. Hurd is asking the global scientific community to participate in CBD research.

 

A 2014 report in The Journal of the American Medical Association (JAMA), discovered the annual overdose rates were roughly 25 percent lower in states that legalized medicinal cannabis compared with those that did not. Other researchers have reached similar conclusions as to the potential of cannabis’ use in the treatment of opioid addiction.

 

Obtaining permission to perform research on the non-psychoactive cannabidiol remains incredibly difficult in the United States as cannabidiol was ruled by the DEA in December to be a Schedule I Narcotic.

 

 This article was originally published on Marijuana.com

 

About Monterey Bud: Born in Long Beach, raised on the central coast: I surf, dab, burn, and blog – though not necessarily in that order. I'm a husband, a father and a lifelong consumer of connoisseur grade weed. I don't drink alcohol or consume any other "drugs." I consider myself to be living proof that weed is not a gateway drug. If it were, I'd be in some serious trouble. Instead, as a 50-year-old ex-realtor that has been smoking weed for nearly 80% of my life (just did the math) ... I can only say, marijuana is safer than prescription pills or alcohol could ever hope to be for calming what stirs the savage beast.

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.